{
    "nctId": "NCT04654195",
    "briefTitle": "Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient",
    "officialTitle": "Associations Between Genetic Polymorphisms of Drug Transporter Genes and Toxicity of Doxorubicin and Cyclophosphamide Chemotherapy in Breast Cancer Patients",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer Patients",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": ".1-The frequency of the genetic polymorphisms of ABCB1 in breast cancer patien",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. women who has confirmed diagnosis of breast cancer.\n2. patient who will be treated with cyclophosphamide and doxorubicin(AC) regimen only .\n3. patient take drug regimen for first time.\n\nExclusion Criteria:\n\n- 1. Patients with metastatic disease and with other previous tumors were excluded from this study 2. Pregnant or nursing female. 3. The patients who were diagnosed with cardiovascular disease or with low left ventricular ejection fraction.\n\n4 .patients who had benign breast cancers, or had no clinical pathological information",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}